Health Care & Life Sciences » Biotechnology | PanGen Biotech Inc.

PanGen Biotech Inc.

PanGen Biotech Inc.
Stock Exchange Korea Exchange
EPS
KRW665
Market Cap
KRW160.54 B
Shares Outstanding
9.64 M
Public Float
6.05 M

Profile

Address
4/F, YeongtongInnoplex II
Suwon GY 16675
Korea, Republic Of
Employees -
Website http://www.pangen.com
Updated 09/14/2018
PanGen Biotech, Inc. engages in the development of biopharmaceutical products. Its products include biosimilar erythropoietin, factor VIII and biosimilar G-CSF. The company was founded on January 29, 2010 and is headquartered in Suwon, South Korea.

Financials

View All
Created with Highcharts 5.0.14PanGen Biotech Inc.Net Income. Fiscal year is January-December. All values KRW Millions.1 3671 3672 1202 1202 6382 6385 1255 1257 0167 0162013201420152016201702k4k6k8k
Created with Highcharts 5.0.14PanGen Biotech Inc.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.3 2123 2123 4003 4003 7313 7311 4611 4612 3732 3732013201420152016201701k2k3k4k

Young-Boo Kim
Co-Chief Executive Officer & Director
Jae-Seung Yoon
Co-Chief Executive Officer & Director